Entities / Company
Thermo Fisher Scientific (Netherlands).
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 48
What's happening
Gone quiet
No new reports in 90+ days-
Thermo Fisher Scientific, Sharp Services LLC, and PAREXEL International lead the clinical trial supply market.Some support2 reports1 development inside
-
Leerink Partners cut price target on Thermo Fisher Scientific (Netherlands) on June 23, 2025.Speculative1 report
-
Barclays adjusted its price target for Thermo Fisher Scientific (Netherlands) on June 24, 2025.Speculative1 report
-
Several pharmaceutical companies are listed in the CDMO market report and ensure compliance with FDA standards.Some support1 report1 development inside
-
Cambrex and Thermo Fisher Scientific (Netherlands) are collaborating as CDMOs to support Adial Pharmaceuticals, Inc.'s drug development.Speculative1 report
-
The biopharmaceuticals manufacturing consumables testing market is growing, driven by demand for validated products, while US tariffs are simultaneously escalating costs for critical testing consumables.Speculative1 report
-
Biodesix, a COE for NGS Diagnostics, provided data to Thermo Fisher Scientific for an FDA regulatory submission.Some support2 reports
-
Thermo Fisher Scientific, Bruker, and Humana are highlighted for their contributions to scientific instruments, healthcare, and Medicare Advantage markets.Speculative1 report
-
UBS downgraded Thermo Fisher Scientific stock rating on July 9, 2025.Speculative1 report
-
Market expects decline in earnings for Thermo Fisher Scientific (Netherlands) as of July 16, 2025.Some support1 report
-
Both Simpson and Thermo Fisher Scientific were profitable companies analyzed for investment risk on August 9, 2025.Some support1 report
-
Maravai LifeSciences Holdings, Inc. appointed Bernd Brust as CEO and Raj Asarpota as CFO in August 2025.Some support2 reports
-
Thermo Fisher Scientific announced innovations advancing scientific discovery in biomarker research and cell therapy development.Some support2 reports1 development inside
-
Thermo Fisher Scientific and Syncell, Inc. formed a strategic co-marketing agreement to advance proteomics.Some support1 report
-
Thermo Fisher Scientific received an outperform rating and its stock performance was contrasted with the S&P 500 on August 20, 2025.Some support2 reports
-
Thermo Fisher Scientific acquired Sanofi's factory on September 3, 2025.Well supported5 reports
No events began in the chosen period. Widen it, or reset.
Connections
The 2 strongest of 48, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.History
Events by the month they beganJune 2026
16 events- Thermo Fisher Scientific, Sharp Services LLC, and PAREXEL International lead the clinical trial supply market.
- Leerink Partners cut price target on Thermo Fisher Scientific (Netherlands) on June 23, 2025.
- Barclays adjusted its price target for Thermo Fisher Scientific (Netherlands) on June 24, 2025.
- Several pharmaceutical companies are listed in the CDMO market report and ensure compliance with FDA standards.
- Cambrex and Thermo Fisher Scientific (Netherlands) are collaborating as CDMOs to support Adial Pharmaceuticals, Inc.'s drug development.
- The biopharmaceuticals manufacturing consumables testing market is growing, driven by demand for validated products, while US tariffs are simultaneously escalating costs for critical testing consumables.
- Biodesix, a COE for NGS Diagnostics, provided data to Thermo Fisher Scientific for an FDA regulatory submission.
- Thermo Fisher Scientific, Bruker, and Humana are highlighted for their contributions to scientific instruments, healthcare, and Medicare Advantage markets.
- UBS downgraded Thermo Fisher Scientific stock rating on July 9, 2025.
- Market expects decline in earnings for Thermo Fisher Scientific (Netherlands) as of July 16, 2025.
- Both Simpson and Thermo Fisher Scientific were profitable companies analyzed for investment risk on August 9, 2025.
- Maravai LifeSciences Holdings, Inc. appointed Bernd Brust as CEO and Raj Asarpota as CFO in August 2025.
- Thermo Fisher Scientific announced innovations advancing scientific discovery in biomarker research and cell therapy development.
- Thermo Fisher Scientific and Syncell, Inc. formed a strategic co-marketing agreement to advance proteomics.
- Thermo Fisher Scientific received an outperform rating and its stock performance was contrasted with the S&P 500 on August 20, 2025.
- Thermo Fisher Scientific acquired Sanofi's factory on September 3, 2025.